1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Kohno, T. Kobayashi, K. Maeda, T. Sato, K. Takashima, A. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking US Biochemistry BICHAW 0033 0006-2960 35 16094 16104 10.1021/bi961598j 8973180 Three-dimensional structures of the amyloid beta peptide (25-35) in membrane-mimicking environment. 1996 10.2210/pdb1qcm/pdb pdb_00001qcm 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 1061.278 AMYLOID BETA PEPTIDE RESIDUES 25 - 35 1 nat polymer no no GSNKGAIIGLM GSNKGAIIGLM A polypeptide(L) n n n n n n n n n n n human Homo sample 9606 Homo sapiens database_2 pdbx_database_status pdbx_struct_assembly pdbx_struct_oper_list repository Initial release Version format compliance Version format compliance Database references Derived calculations Other 1 0 1997-07-07 1 1 2008-03-24 1 2 2011-07-13 1 3 2022-03-02 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_database_status.process_site Y BNL 1996-07-19 REL 20 GLY 1 n 1 GLY 1 A SER 2 n 2 SER 2 A ASN 3 n 3 ASN 3 A LYS 4 n 4 LYS 4 A GLY 5 n 5 GLY 5 A ALA 6 n 6 ALA 6 A ILE 7 n 7 ILE 7 A ILE 8 n 8 ILE 8 A GLY 9 n 9 GLY 9 A LEU 10 n 10 LEU 10 A MET 11 n 11 MET 11 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 1 A SER 2 -168.58 47.17 2 A SER 2 -63.04 -169.67 3 A SER 2 -171.62 58.95 3 A ASN 3 -170.89 49.18 4 A SER 2 75.49 80.65 4 A ASN 3 78.47 43.45 5 A SER 2 62.94 127.41 5 A ASN 3 -172.36 54.04 7 A SER 2 75.53 141.65 7 A ASN 3 -156.85 51.36 9 A ASN 3 -147.11 52.06 10 A ASN 3 72.76 54.84 11 A ASN 3 -163.83 49.85 15 A SER 2 -118.45 72.90 15 A ASN 3 167.07 57.67 16 A ASN 3 -143.81 44.91 17 A ASN 3 73.33 55.92 19 A ASN 3 175.34 51.26 20 A ASN 3 -167.52 53.67 AMYLOID BETA PEPTIDE (25-35), NMR, 20 STRUCTURES 1 Y N A LYS 4 A LYS 4 HELX_P A ILE 7 A ILE 7 1 1 4 AMYLOID GLYCOPROTEIN, AMYLOID, ALZHEIMER'S DISEASE, DOWN'S SYNDROME, NEURONE, TRANSMEMBRANE, ALTERNATIVE SPLICING, SERINE PROTEASE INHIBITOR, DISEASE MUTATION A4_HUMAN UNP 1 1 P05067 MLPGLALLLLAAWTARALEVPTDGNAGLLAEPQIAMFCGRLNMHMNVQNGKWDSDPSGTKTCIDTKEGILQYCQEVYPEL QITNVVEANQPVTIQNWCKRGRKQCKTHPHFVIPYRCLVGEFVSDALLVPDKCKFLHQERMDVCETHLHWHTVAKETCSE KSTNLHDYGMLLPCGIDKFRGVEFVCCPLAEESDNVDSADAEEDDSDVWWGGADTDYADGSEDKVVEVAEEEEVAEVEEE EADDDEDDEDGDEVEEEAEEPYEEATERTTSIATTTTTTTESVEEVVREVCSEQAETGPCRAMISRWYFDVTEGKCAPFF YGGCGGNRNNFDTEEYCMAVCGSAMSQSLLKTTQEPLARDPVKLPTTAASTPDAVDKYLETPGDENEHAHFQKAKERLEA KHRERMSQVMREWEEAERQAKNLPKADKKAVIQHFQEKVESLEQEAANERQQLVETHMARVEAMLNDRRRLALENYITAL QAVPPRPRHVFNMLKKYVRAEQKDRQHTLKHFEHVRMVDPKKAAQIRSQVMTHLRVIYERMNQSLSLLYNVPAVAEEIQD EVDELLQKEQNYSDDVLANMISEPRISYGNDALMPSLTETKTTVELLPVNGEFSLDDLQPWHSFGADSVPANTENEVEPV DARPAADRGLTTRPGSGLTNIKTEEISEVKMDAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIATVIVITL VMLKKKQYTSIHHGVVEVDAAVTPEERHLSKMQQNGYENPTYKFFEQMQN 696 706 1QCM 1 11 P05067 A 1 1 11 1 P 1